Precise theranostic nanomedicines for inhibiting vulnerable atherosclerotic plaque progression through regulation of vascular smooth muscle cell phenotype switching

Conclusions: The theranostic ICG/SRT@HSA-pept NMs showed great potential for the precise identification and targeted treatment of atherosclerotic diseases.

Source: Theranostics - June 20, 2018 Category: Molecular Biology Authors: Sai Ma, Seyed Mohammad Motevalli, Jiangwei Chen, Meng-Qi Xu, Yabin Wang, Jing Feng, Ya Qiu, Dong Han, Miaomiao Fan, Meiling Ding, Li Fan, Weisheng Guo, Xing-Jie Liang, Feng Cao Tags: Research Paper Source Type: research